Achieve Life Sciences, Inc. (ACHV) vs Design Therapeutics, Inc. (DSGN)
A side-by-side comparison of Achieve Life Sciences, Inc. and Design Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACHV
Achieve Life Sciences, Inc.
$7.18HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
DSGN
Design Therapeutics, Inc.
$12.16HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Total return — ACHV vs DSGN
growth of $100 · dividends reinvested · last 6yACHV -44.9% (-9.4%/yr)DSGN -70.1% (-18.2%/yr)ACHV compounded faster over this window
ACHV DSGN
ACHV vs DSGN: by the numbers
- •DSGN is the larger company ($759M vs $737M market cap).
Metrics side by side
Valuation
| Metric | ACHV | DSGN |
|---|---|---|
| P/B ratio | N/A | 3.76 |
Profitability
| Metric | ACHV | DSGN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -35.07% |
| ROIC | N/A | -38.92% |
Growth (annualized)
| Metric | ACHV | DSGN |
|---|---|---|
| Total return CAGR (5Y) | -4.33% | -3.82% |
Frequently asked
- How have ACHV and DSGN total returns compared?
- Over the past 5 years, ACHV delivered -4.33% and DSGN delivered -3.82% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.